The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus

被引：0
|
作者：
Xueyang Zhang
Ran Bai
Yong Jia
Junwei Zong
Yongbo Wang
Yanan Dong
机构：
[1] The first affiliated Hospital of Dalian Medical University,Department of Endocrinology
[2] Dalian,Institute of Integrative Medicine
[3] Liaoning,Department of Orthopedics
[4] Dalian Medical University,undefined
[5] The first affiliated Hospital of Dalian Medical University,undefined
[6] Dalian,undefined
[7] Liaoning,undefined
来源：
International Journal of Diabetes in Developing Countries | 2020年 / 40卷
关键词：
Liraglutide; Nonalcoholic fatty liver disease; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：491 / 499
页数：8
相关论文
共 50 条
  • [21] Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus
    Paola Portillo-Sanchez
    Kenneth Cusi
    Clinical Diabetes and Endocrinology, 2 (1):
  • [22] Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
    Cho, Hyo Jung
    Hwang, Sunhyuk
    Park, Jong Ik
    Yang, Min Jae
    Hwang, Jae Chul
    Yoo, Byung Moo
    Lee, Kee Myung
    Shin, Sung Jae
    Lee, Kwang Jae
    Kim, Jin Hong
    Cheong, Jae Youn
    Cho, Sung Won
    Kim, Soon Sun
    GUT AND LIVER, 2019, 13 (04) : 440 - 449
  • [23] Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus
    Cusi, Kenneth
    Roden, Michael
    Barritt, Alfred S.
    Firpi, Roberto J.
    Clark, Virginia
    Klein, Samuel
    Lok, Anna
    Newsome, Philip
    Corbin, Karen
    Vos, Miriam B.
    Reddy, Rajender
    Schoen, Cheryl
    Mospan, Andrea R.
    Taunk, Jawahar L.
    Wyne, Kathleen
    Neuschwander-Tetri, Brent
    Sanyal, Arun
    DIABETES, 2020, 69
  • [24] Comparing the Association of Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease With Type 1 vs Type 2 Diabetes Mellitus
    Ghai, Megan B.
    Rangan, Pooja
    Han, Ma Ai Thanda
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1149 - S1150
  • [25] Liraglutide, sitagliptin, and insulin glargine added to metformin: The effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    Science Foundation in China, 2019, (03) : 32 - 32
  • [26] Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Yan, Jinhua
    Yao, Bin
    Kuang, Hongyu
    Yang, Xubin
    Huang, Qin
    Hong, Tianpei
    Li, Yushu
    Dou, Jingtao
    Yang, Wenying
    Qin, Guijun
    Yuan, Huijuan
    Xiao, Xinhua
    Luo, Sihui
    Shan, Zhongyan
    Deng, Hongrong
    Tan, Ying
    Xu, Fen
    Xu, Wen
    Zeng, Longyi
    Kang, Zhuang
    Weng, Jianping
    HEPATOLOGY, 2019, 69 (06) : 2414 - 2426
  • [27] Effect of Dapagliflozin on Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Single-Center Survey
    Das, Chandan
    Tripathy, Debasmita
    Swain, Surendranath
    Sudhakaran, Navin
    Uthansingh, Kanishka
    Mallick, Pradeep
    Pati, Girish K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [28] Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
    Han, Xinyu
    Zhang, Xin
    Liu, Zhenqiu
    Fan, Hong
    Guo, Chengnan
    Wang, Haili
    Gu, Yu
    Zhang, Tiejun
    JOURNAL OF DIABETES, 2024, 16 (05)
  • [29] Dapagliflozin Therapy Curative Effect Observation on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Hu, Chen Liang
    Wang, Yu Chuan
    Xi, Yu
    Yao, Xin Ming
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 : 122 - 129
  • [30] Response to "Effect of metabolic components on incident type 2 diabetes mellitus in nonalcoholic fatty liver disease subjects'
    Fukuda, Takuya
    Hamaguchi, Masahide
    Fukui, Michiaki
    LIVER INTERNATIONAL, 2016, 36 (03) : 462 - 462
12345